Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Herpesviridae Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00000769
What this trial is testing

A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Large-scale testing (Phase 3)UnknownNCT05669625
What this trial is testing

A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine

Who this might be right for
Varicella
China National Biotec Group Company Limited 12,440
Large-scale testing (Phase 3)Study completedNCT00001082
What this trial is testing

The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 505
Large-scale testing (Phase 3)Study completedNCT00496327
What this trial is testing

Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)

Who this might be right for
Varicella
Merck Sharp & Dohme LLC 100
Not applicableLooking for participantsNCT06898203
What this trial is testing

Precision Imaging to Evaluate Kaposi Sarcoma

Who this might be right for
Kaposi Sarcoma
Washington University School of Medicine 180
Early research (Phase 1)WithdrawnNCT04094766
What this trial is testing

Safety and Efficacy of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy in R/R Acute B Lymphoblastic Leukemia

Who this might be right for
Refractory B Acute Lymphoblastic LeukemiaRelapse B Acute Lymphoblastic Leukemia
Second Affiliated Hospital of Xi'an Jiaotong University
Early research (Phase 1)Study completedNCT00036946
What this trial is testing

VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Regeneron Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00115310
What this trial is testing

Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Who this might be right for
Peripheral Nervous System DiseasesPainNeuralgia+2 more
NeurogesX 400
Early research (Phase 1)Study completedNCT00003720
What this trial is testing

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
Pfizer
Large-scale testing (Phase 3)UnknownNCT00445497
What this trial is testing

Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeutropenia+3 more
Clatterbridge Centre for Oncology 400
Early research (Phase 1)UnknownNCT00587496
What this trial is testing

30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers

Who this might be right for
Herpes Simplex
National Eye Institute (NEI) 60
Testing effectiveness (Phase 2)UnknownNCT00299260
What this trial is testing

CMV Glycoprotein B Vaccine in Allograft Recipients

Who this might be right for
Cytomegalovirus Infections
University College, London 140
Large-scale testing (Phase 3)Active Not RecruitingNCT03914625
What this trial is testing

Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic LeukemiaB Lymphoblastic LymphomaDown Syndrome
National Cancer Institute (NCI) 6,720
Large-scale testing (Phase 3)Study completedNCT00278408
What this trial is testing

Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 700
Early research (Phase 1)Study completedNCT00390117
What this trial is testing

AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 34
Not applicableNot Yet RecruitingNCT06542289
What this trial is testing

Safety and Effectiveness of the BlinkER System in Participants With Facial Nerve Palsy

Who this might be right for
Bell's PalsyRamsay Hunt SyndromeLyme Disease+1 more
Neurotrigger Ltd 80
Not applicableUnknownNCT04782674
What this trial is testing

Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related Diseases

Who this might be right for
EBV Infection
Beijing Friendship Hospital 40
Not applicableStudy completedNCT01484067
What this trial is testing

Study of a Cold Sore Patch for the Treatment of Herpes Labialis

Who this might be right for
Herpes Labialis
Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc. 472
Testing effectiveness (Phase 2)Ended earlyNCT00913692
What this trial is testing

Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis

Who this might be right for
Herpes LabialisHerpes Simplex Virus
National Institute of Allergy and Infectious Diseases (NIAID) 11
Early research (Phase 1)Ended earlyNCT04762511
What this trial is testing

A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years

Who this might be right for
Herpes Simplex
GlaxoSmithKline 17
Next Page